MedTrace Logo

Improving Cardiac Secondary Prevention

NCT03269708 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2024-05-07

No results posted yet for this study

Summary

The purpose of this study is to determine whether providing individuals with personalized information on cellular aging, including telomere length, will stimulate them to adhere to cardiac prevention strategies and improve exercise capacity.

Conditions

Interventions

BEHAVIORAL

Education regarding telomere length

Teaching concepts of cellular aging and telomere length

Sponsors & Collaborators

  • Western University, Canada

    lead OTHER

Principal Investigators

  • J. Geoffrey Pickering, MD PhD · Western Faculty

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03269708 on ClinicalTrials.gov